Retractable Technologies, Inc. (RVP)
0.73
+0.01
(+1.14%)
USD |
NYAM |
Aug 28, 16:00
0.73
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies Enterprise Value : -16.96M for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | -16.96M |
| August 27, 2026 | -17.20M |
| August 26, 2026 | -16.96M |
| August 25, 2026 | -16.81M |
| August 24, 2026 | -16.96M |
| August 21, 2026 | -16.96M |
| August 20, 2026 | -16.96M |
| August 19, 2026 | -17.26M |
| August 18, 2026 | -17.26M |
| August 17, 2026 | -17.86M |
| August 14, 2026 | -18.08M |
| August 13, 2026 | -18.49M |
| August 12, 2026 | -18.62M |
| August 11, 2026 | -18.54M |
| August 10, 2026 | -18.75M |
| August 07, 2026 | -18.75M |
| August 06, 2026 | -18.54M |
| August 05, 2026 | -18.76M |
| August 04, 2026 | -18.75M |
| August 03, 2026 | -19.05M |
| July 31, 2026 | -19.05M |
| July 30, 2026 | -18.75M |
| July 29, 2026 | -18.75M |
| July 28, 2026 | -18.75M |
| July 27, 2026 | -18.75M |
| Date | Value |
|---|---|
| July 24, 2026 | -18.45M |
| July 23, 2026 | -18.45M |
| July 22, 2026 | -18.45M |
| July 21, 2026 | -18.45M |
| July 20, 2026 | -18.16M |
| July 17, 2026 | -18.32M |
| July 16, 2026 | -18.13M |
| July 15, 2026 | -17.26M |
| July 14, 2026 | -18.15M |
| July 13, 2026 | -18.31M |
| July 10, 2026 | -18.31M |
| July 09, 2026 | -17.95M |
| July 08, 2026 | -17.83M |
| July 07, 2026 | -17.52M |
| July 06, 2026 | -16.84M |
| July 02, 2026 | -16.96M |
| July 01, 2026 | -16.99M |
| June 30, 2026 | -17.26M |
| June 29, 2026 | -13.37M |
| June 26, 2026 | -13.59M |
| June 25, 2026 | -13.66M |
| June 24, 2026 | -12.92M |
| June 23, 2026 | -13.91M |
| June 22, 2026 | -14.20M |
| June 18, 2026 | -14.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 222.27B |
| AngioDynamics, Inc. | 618.04M |
| Alphatec Holdings, Inc. | 1.950B |
| AtriCure, Inc. | 2.375B |
| Baxter International, Inc. | 20.19B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.831M |
| Revenue (Quarterly) | 7.201M |
| Total Expenses (Quarterly) | 4.370M |
| EPS Diluted (Quarterly) | 0.0926 |
| Gross Profit Margin (Quarterly) | 2.95% |
| Profit Margin (Quarterly) | 39.31% |
| Earnings Yield | -16.49% |
| Normalized Earnings Yield | -15.27 |